Aldeyra Therapeutics Inc (STU:137)
€ 5.196 0.038 (0.74%) Market Cap: 265.33 Mil Enterprise Value: 167.12 Mil PE Ratio: 0 PB Ratio: 2.88 GF Score: 38/100

Q4 2022 Aldeyra Therapeutics Inc Earnings Call Transcript

Mar 09, 2023 / 01:00PM GMT
Release Date Price: €6.91 (-0.49%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Full Year 2022 Financial Results Conference Call. (Operator Instructions)

I would now like to hand the call over to -- the conference call over to Mr. Bruce Greenberg, the company's Interim Chief Financial Officer. Please go ahead, sir, Bruce Greenberg.

Bruce Greenberg
Aldeyra Therapeutics, Inc. - VP of Finance, Interim CFO & Treasurer

Thank you, and good morning, everyone. With me today is Dr. Todd Brady, our President and Chief Executive Officer. This morning, we issued a press release reporting recent corporate highlights and our financial results for the year ended December 31, 2022. A copy of the press release is available on the Investors & Media section of our website at www.aldeyra.com.

Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include, but are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot